Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas [Phase 2]
Phase 2 trial evaluating cetuximab with radiation therapy for surgically resectable esophageal and gastroesophageal junction carcinomas; res…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer [Phase 2]
This is a Phase 2 trial evaluating the combination of 5-FU, oxaliplatin, and lapatinib with radiation therapy for HER2-positive esophagogast…
-
CLINICAL_TRIALS withdrawal · 2016-04-21Clinical Trial Update: Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. [Phase 1]
A Phase 1 trial of TH-302 (evofosfamide) in combination with preoperative chemoradiotherapy for esophageal cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 study evaluating pemetrexed in combination with cisplatin and radiation therapy for esophageal and gastroesophageal junction cance…
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. [Phase 2]
A Phase 2 clinical trial is evaluating Endostatin in combination with Oxaliplatin and radiotherapy for esophageal cancer; the trial's status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: IMRT Tomotherapy for Esophagus Cancer [Phase 1]
A Phase 1 trial evaluating IMRT Tomotherapy for esophageal cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2016-04-05Clinical Trial Update: A Pilot Study of the Effectiveness of Acceptance and Commitment Therapy With a Post-Upper GI Cancer Population [NA]
A pilot study evaluating Acceptance and Commitment Therapy for patients with post-upper GI cancer (esophageal cancer) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer [Phase 2]
Phase 2 trial evaluating everolimus in patients with previously treated unresectable or metastatic esophageal or gastric cancer has complete…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer [NA]
A completed clinical trial suggests that pronase improves the efficacy of chromoendoscopy screening for esophageal neoplasms (esophageal can…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Value of PET-CT in Radiation Treatment Planning for Patients With Esophageal Cancer
This clinical trial update notes the completion of a study evaluating the value of PET-CT in planning radiation therapy for patients with es…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer [Phase 2]
Phase II study to evaluate icotinib with concurrent radiotherapy in elderly patients with esophageal cancer. The update does not report resu…
-
CLINICAL_TRIALS trial_result · 2016-03-18Clinical Trial Update: Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients
The trial investigating radiotherapy dose and volume parameters and their impact on postoperative complications in esophageal cancer was ter…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 study of a modified docetaxel-cisplatin-5-FU regimen with bevacizumab in unresectable or metastatic gastroesophageal adenocarcinoma …
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Barrett&Apos;s Intervention for Dysplasia by Endoscopy [NA]
This document notes the completion of a clinical trial evaluating an endoscopic intervention for dysplasia in Barrett's esophagus. The study…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: The Predictive Value of CT-PET in Esophageal Cancer
A completed clinical trial evaluating the predictive value of CT-PET imaging for outcomes in esophageal cancer.
-
CLINICAL_TRIALS withdrawal · 2016-03-08Clinical Trial Update: Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers [Phase 2]
Phase 2 trial of personalized therapy for esophagogastric cancer using thymidylate synthase genetic markers has been withdrawn.
-
CLINICAL_TRIALS research · 2016-02-26Clinical Trial Update: DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer [Phase 1, Phase 2]
Clinical trial update for dendritic cell vaccine combined with cytokine-induced killer cells in esophageal cancer (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Esophageal Stump Washout [NA]
The esophageal stump washout trial sponsored by Kantonsspital Liestal has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: CCRT for Esophageal Cancer. [Phase 2]
The document announces completion of a Phase 2 trial of concurrent chemoradiotherapy for esophageal cancer, involving oxaliplatin and paclit…
-
CLINICAL_TRIALS research · 2016-02-17Clinical Trial Update: Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer [Phase 2]
A Phase II clinical trial evaluating thalidomide in combination with concurrent chemoradiotherapy for esophageal cancer.
-
FDA approval · 2016-02-17FDA Approved: FLUOROURACIL — Original Application (Sagent Pharmaceuticals)
FDA approves an Original Application for Fluorouracil from Sagent Pharmaceuticals, establishing a generic injectable form of the chemotherap…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Study of Apatinib in Metastatic Esophageal Cancer [Phase 2]
A Phase 2 clinical trial is studying apatinib for metastatic esophageal cancer; the current status of the trial is not disclosed in the upda…
-
CLINICAL_TRIALS withdrawal · 2016-02-15Clinical Trial Update: Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Phase 1, Phase 2]
A phase 1/2 trial of Epirubicin (Pharmorubicin), Carboplatin (Paraplatin) and Capecitabine (Xeloda) for unresectable locally advanced or met…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer [Phase 2]
Phase 2 clinical trial in locally advanced esophageal cancer evaluated irinotecan, cisplatin, and bevacizumab with radiation therapy and sur…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers [Phase 2]
A Phase 2 trial of docetaxel in combination with capecitabine for gastric and esophageal cancers was terminated; results have been posted.